ALDEYRA THERAPEUTICS INC's ticker is ALDX and the CUSIP is 01438T106. A total of 138 filers reported holding ALDEYRA THERAPEUTICS INC in Q2 2021. The put-call ratio across all filers is 0.74 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $288,910 | -20.0% | 43,250 | +0.4% | 0.00% | -33.3% |
| Q2 2023 | $361,257 | -5.7% | 43,058 | +11.6% | 0.00% | 0.0% |
| Q1 2023 | $383,109 | +38.5% | 38,581 | -3.0% | 0.00% | +50.0% |
| Q4 2022 | $276,702 | +62.8% | 39,756 | +25.0% | 0.00% | 0.0% |
| Q3 2022 | $170,000 | +23.2% | 31,813 | -8.0% | 0.00% | +100.0% |
| Q2 2022 | $138,000 | -47.9% | 34,581 | -42.1% | 0.00% | -66.7% |
| Q1 2022 | $265,000 | -1.5% | 59,706 | -11.2% | 0.00% | 0.0% |
| Q4 2021 | $269,000 | -56.8% | 67,223 | -5.2% | 0.00% | -50.0% |
| Q3 2021 | $623,000 | -27.6% | 70,915 | -6.6% | 0.01% | -25.0% |
| Q2 2021 | $860,000 | +3.1% | 75,903 | +8.1% | 0.01% | 0.0% |
| Q1 2021 | $834,000 | +75.6% | 70,227 | +1.5% | 0.01% | +60.0% |
| Q4 2020 | $475,000 | – | 69,170 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SPHERA FUNDS MANAGEMENT LTD. | 1,009,131 | $7,568,000 | 1.15% |
| Knoll Capital Management, LLC | 124,096 | $931,000 | 0.96% |
| 683 Capital Management, LLC | 1,000,000 | $7,500,000 | 0.66% |
| Perceptive Advisors | 3,085,458 | $23,141,000 | 0.65% |
| MANGROVE PARTNERS IM, LLC | 324,019 | $2,430,000 | 0.16% |
| Stanley-Laman Group, Ltd. | 64,029 | $480,000 | 0.11% |
| WOODSTOCK CORP | 67,759 | $508,000 | 0.10% |
| Hikari Power Ltd | 107,858 | $809,000 | 0.10% |
| ARDSLEY ADVISORY PARTNERS LP | 45,000 | $336,000 | 0.05% |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 750,000 | $5,625,000 | 0.01% |